Venclyxto (venetoclax): Reviews and patient testimonials
Back to the list of medications
Medication indications
Venclyxto film-coated tablets
Venclyxto monotherapy is indicated for the treatment of chronic lymphocytic leukaemia (CLL) in the presence of 17p deletion or TP53 mutation in adult patients who are unsuitable for or have failed a B-cell receptor pathway inhibitor.
Venclyxto monotherapy is indicated for the treatment of CLL in the absence of 17p deletion or TP53 mutation in adult patients who have failed both chemoimmunotherapy and a B-cell receptor pathway inhibitor.
Route of administration: Oral
Molecule: venetoclax
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.